Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: Tender for a non-exclusive discount agreement for the active ingredient Morphine (exclusively in the forms FTA + HKP + SMT) issued by DAK-Gesundheit in Hamburg, Germany. The contract duration is from January 1, 2027, to December 31, 2028, with an option for a one-year extension.
Scope Of Work: The tender involves establishing a framework discount agreement for Morphine, specifically in the forms FTA, HKP, and SMT. This agreement is to be concluded under Section 130a(8) of the German Social Code, allowing health insurance funds and pharmaceutical companies to enter into discount agreements for medicines. DAK-Gesundheit aims to finalize contracts with interested pharmaceutical companies before new agreements come into force on January 1, 2027, and will continue until December 31, 2028, with an optional one-year extension. Interested bidders must submit relevant documents, including a letter of offer, acknowledgment of contractual terms, and completed annexes, by email to DAK-Gesundheit.
Qualification Criterion: Bidders must submit the following documents to DAK-Gesundheit: an offer letter, acknowledgment of the contractual terms including specified discounts, and completed Annexes 1 and 2, which list the medicines related to Morphine. These documents must be sent via email to [email protected] by the 5th of the month preceding the desired contract start date. Late submissions will not be considered for the initial contract period but may be accepted for later entries.
Purchaser contact is for registered users
Login to see detailsTender details are for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| Operation of a Dynamic Procurement System for Laboratory Consumables. | Germany | 152653979 | 02 Jan 2027 |
| Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Ustekinumab from January 1, 2027 | Germany | 152653877 | 10 Aug 2028 |
| Open House Biologics Discount Agreements 2026-09 - Etanercept | Germany | 152653671 | 31 Dec 2026 |
| Delivery of Cleaning Products, Anker Facilities, Gu Etc., Government of Lower Bavaria | Germany | 152653374 | 17 Dec 2026 |
| Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Tacrolimus (Atc: D11ah01). | Germany | 152653349 | 27 Oct 2028 |